[BOOK][B] In all likelihood: statistical modelling and inference using likelihood
Y Pawitan - 2001 - books.google.com
Based on a course in the theory of statistics this text concentrates on what can be achieved
using the likelihood/Fisherian method of taking account of uncertainty when studying a …
using the likelihood/Fisherian method of taking account of uncertainty when studying a …
False discovery rate, sensitivity and sample size for microarray studies
Motivation: In microarray data studies most researchers are keenly aware of the potentially
high rate of false positives and the need to control it. One key statistical shift is the move away …
high rate of false positives and the need to control it. One key statistical shift is the move away …
Most genetic risk for autism resides with common variation
…, AB Lee, M Mahajan, D Manaa, Y Pawitan… - Nature …, 2014 - nature.com
A key component of genetic architecture is the allelic spectrum influencing trait variability.
For autism spectrum disorder (herein termed autism), the nature of the allelic spectrum is …
For autism spectrum disorder (herein termed autism), the nature of the allelic spectrum is …
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
Background Whether schizophrenia and bipolar disorder are the clinical outcomes of discrete
or shared causative processes is much debated in psychiatry. We aimed to assess genetic …
or shared causative processes is much debated in psychiatry. We aimed to assess genetic …
[HTML][HTML] Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan, J Bjöhle, L Amler, AL Borg, S Egyhazi… - Breast cancer …, 2005 - Springer
Introduction Adjuvant breast cancer therapy significantly improves survival, but overtreatment
and undertreatment are major problems. Breast cancer expression profiling has so far …
and undertreatment are major problems. Breast cancer expression profiling has so far …
Statistical challenges associated with detecting copy number variations with next-generation sequencing
Motivation: Analysing next-generation sequencing (NGS) data for copy number variations (CNVs)
detection is a relatively new and challenging field, with no accepted standard …
detection is a relatively new and challenging field, with no accepted standard …
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
Perturbations of the p53 pathway are associated with more aggressive and therapeutically
refractory tumors. However, molecular assessment of p53 status, by using sequence analysis …
refractory tumors. However, molecular assessment of p53 status, by using sequence analysis …
[BOOK][B] Generalized linear models with random effects: unified analysis via H-likelihood
Y Lee, JA Nelder, Y Pawitan - 2018 - taylorfrancis.com
This is the second edition of a monograph on generalized linear models with random effects
that extends the classic work of McCullagh and Nelder. It has been thoroughly updated, with …
that extends the classic work of McCullagh and Nelder. It has been thoroughly updated, with …
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
…, B Mow, TC Putti, J Smeds, T Lindahl, Y Pawitan… - Cancer research, 2006 - AACR
Histologic grading of breast cancer defines morphologic subtypes informative of metastatic
potential, although not without considerable interobserver disagreement and clinical …
potential, although not without considerable interobserver disagreement and clinical …
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
…, B Roizman, J Bergh, Y Pawitan… - Proceedings of the …, 2008 - National Acad Sciences
Individualization of cancer management requires prognostic markers and therapy-predictive
markers. Prognostic markers assess risk of disease progression independent of therapy, …
markers. Prognostic markers assess risk of disease progression independent of therapy, …